 Sanofi SA said Saturday that its multiplesclerosis treatment Lemtrada has been approved for sale in the US nearly a year after regulators rejected the drug because of concerns about its serious side effects and the way the drug was tested in clinical studies The drug will be marketed by Cambridge Massbased Genzyme Corp which Sanofi acquired in  for  billion Former Sanofi Chief Executive Christopher Viehbacher who was fired last month amid tensions with the French pharmaceutical companys board had made
  